Our recent study identified FBXW2 as a tumor suppressor via promoting ubiquitylation of SKP2 (S phase kinase-associated protein 2) for targeted degradation to inhibit growth and survival of lung cancer cells4. This evidence concerns the gene SKP2 and lung carcinoma.